Literature DB >> 18218918

Effect of airways constriction on exhaled nitric oxide.

Sylvia Verbanck1, Yannick Kerckx, Daniel Schuermans, Walter Vincken, Manuel Paiva, Alain Van Muylem.   

Abstract

While airway constriction has been shown to affect exhaled nitric oxide (NO), the mechanisms and location of constricted airways most likely to affect exhaled NO remain obscure. We studied the effects of histamine-induced airway constriction and ventilation heterogeneity on exhaled NO at 50 ml/s (Fe(NO,50)) and combined this with model simulations of Fe(NO,50) changes due to constriction of airways at various depths of the lung model. In 20 normal subjects, histamine induced a 26 +/- 15(SD)% Fe(NO,50) decrease, a 9 +/- 6% forced expiratory volume in 1 s (FEV(1)) decrease, a 19 +/- 9% mean forced midexpiratory flow between 25% and 75% forced vital capacity (FEF(25-75)) decrease, and a 94 +/- 119% increase in conductive ventilation heterogeneity. There was a significant correlation of Fe(NO,50) decrease with FEF(25-75) decrease (P = 0.006) but not with FEV(1) decrease or with increased ventilation heterogeneity. Simulations confirmed the negligible effect of ventilation heterogeneity on Fe(NO,50) and showed that the histamine-induced Fe(NO,50) decrease was due to constriction, with associated reduction in NO flux, of airways located proximal to generation 15. The model also indicated that the most marked effect of airways constriction on Fe(NO,50) is situated in generations 10-15 and that airway constriction beyond generation 15 markedly increases Fe(NO,50) due to interference with the NO backdiffusion effect. These mechanical factors should be considered when interpreting exhaled NO in lung disease.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18218918     DOI: 10.1152/japplphysiol.01019.2007

Source DB:  PubMed          Journal:  J Appl Physiol (1985)        ISSN: 0161-7567


  8 in total

1.  Airway calibre variation is a major determinant of exhaled nitric oxide's ability to capture asthma control.

Authors:  Alain Michils; Amaryllis Haccuria; Sebastien Michiels; Alain Van Muylem
Journal:  Eur Respir J       Date:  2017-08-17       Impact factor: 16.671

2.  Quantifying proximal and distal sources of NO in asthma using a multicompartment model.

Authors:  David A Shelley; James L Puckett; Steven C George
Journal:  J Appl Physiol (1985)       Date:  2010-01-21

3.  A multi-scale model of gas transport in the lung to study heterogeneous lung ventilation during the multiple-breath washout test.

Authors:  David Hasler; Pinelopi Anagnostopoulou; Sylvia Nyilas; Philipp Latzin; Johannes Schittny; Dominik Obrist
Journal:  PLoS Comput Biol       Date:  2019-06-17       Impact factor: 4.475

4.  Modeling of the Transport and Exchange of a Gas Species in Lungs With an Asymmetric Branching Pattern. Application to Nitric Oxide.

Authors:  Alexandra Buess; Alain Van Muylem; Antoine Nonclercq; Benoit Haut
Journal:  Front Physiol       Date:  2020-12-10       Impact factor: 4.566

Review 5.  Techniques of assessing small airways dysfunction.

Authors:  William McNulty; Omar S Usmani
Journal:  Eur Clin Respir J       Date:  2014-10-17

6.  Modeling of the Nitric Oxide Transport in the Human Lungs.

Authors:  Cyril Karamaoun; Alain Van Muylem; Benoît Haut
Journal:  Front Physiol       Date:  2016-06-28       Impact factor: 4.566

7.  New data analysis in a population study raises the hypothesis that particle size contributes to the pro-asthmatic potential of small pet animal allergens.

Authors:  Antonios Patelis; Amrita Dosanjh; Maria Gunnbjörnsdottir; Magnus P Borres; Marieann Högman; Kjell Alving; Christer Janson; Andrei Malinovschi
Journal:  Ups J Med Sci       Date:  2015-11-26       Impact factor: 2.384

8.  Oscillating Positive Expiratory Pressure on Respiratory Resistance in Chronic Obstructive Pulmonary Disease With a Small Amount of Secretion: A Randomized Clinical Trial.

Authors:  Ada Clarice Gastaldi; Paolo Paredi; Anjana Talwar; Sally Meah; Peter J Barnes; Omar S Usmani
Journal:  Medicine (Baltimore)       Date:  2015-10       Impact factor: 1.817

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.